Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.

Zhou, Yuqi; Maldini, Colby R; Jadlowsky, Julie; Riley, James L

Zhou, Yuqi; Maldini, Colby R; Jadlowsky, Julie; Riley, James L.

Afiliación

Zhou Y; Department of Microbiology, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maldini CR; Department of Microbiology, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jadlowsky J; Department of Microbiology, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Riley JL; Department of Microbiology, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

J Infect Dis ; 223(12 Suppl 2): 38-45, 2021 02 15.

Article en En | MEDLINE | ID: mdl-33586770

Asunto(s)

Traslado Adoptivo; Linfocitos T CD4-Positivos/inmunología; Infecciones por VIH/terapia; VIH-1/fisiología; Inmunidad Adaptativa; Animales; Infecciones por VIH/inmunología; Infecciones por VIH/virología; VIH-1/genética; Humanos

Palabras clave

T-cell exhaustion; T-cell receptor; antiretroviral therapy; chimeric antigen receptor; ex vivo T-cell expansion; human-immunodeficiency-virus; latency reversing agent

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Infecciones por VIH / VIH-1 / Traslado Adoptivo Idioma: En Revista: J Infect Dis Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google